Evidence of decreased incidence of extra-pyramidal symptoms with intravenous haloperidol

Publisher： Elsevier

ISSN： 0022-3999

Source： Journal of Psychosomatic Research, Vol.55, Iss.2, 2003-08, pp. : 140-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

F response in pyramidal, extrapyramidal and cerebellar lesions

By Jovicic A. Djordjevic D. Jovanovic M. Petkovic S.

Electroencephalography and Clinical Neurophysiology, Vol. 99, Iss. 4, 1996-10 ,pp. : 316-317

Elsevier

Access to resources Recommend Favorite

Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III

By Tchan Michel Sillence David

Journal of Intellectual & Developmental Disability, Vol. 34, Iss. 3, 2009-09 ,pp. : 275-279

Informa Healthcare

Access to resources Recommend Favorite

Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients

By Høiberg M. P. Nielsen B.

Nordic Journal of Psychiatry, Vol. 60, Iss. 3, 2006-05 ,pp. : 207-212

Informa Healthcare

Access to resources Recommend Favorite

Risperidone treatment of neuroleptic-induced tardive extrapyramidal symptoms

By Suenaga Takami Tawara Yasutaka Goto Shinichiro Kouhata Shin-Ichi Kagaya Ariyuki Horiguchi Jun Yamanaka Yusuke Yamawaki Shigeto

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 3, 2000-09 ,pp. : 241-243

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia

By Krausz M. Moritz S.H. Naber D. Lambert M. Andresen B.

European Psychiatry, Vol. 14, Iss. 2, 1999-04 ,pp. : 84-88

Elsevier

Access to resources Recommend Favorite